English
Home > Products > 2859-68-9

China 2859-68-9 Factory

That has a positive and progressive attitude to customer's fascination, our enterprise constantly improves our merchandise high quality to meet the demands of customers and further focuses on safety, reliability, environmental requirements, and innovation of 2859-68-9,CAS NO 2859-68-9,2-Pyridinepropanol,Pyridinepropanol, Through our hard work, we have always been on the forefront of clean technology product innovation. We are a green partner you can rely on. Contact us today for more information!
2859-68-9, When you are keen on any of our items following you view our product list, please feel free to make contact with us for inquiries. You'll be able to send us emails and get in touch with us for consultation and we shall respond for you as soon as we are able to. If it's convenient, you could find out our address in our web site and come to our enterprise. or additional information of our goods by yourself. We're generally ready to build lengthy and steady co-operation relations with any possible shoppers within the associated fields.

Related Products

Hot Products

  • Saffron extract

    Saffron extract

    Product Name:Saffron extract
    Molecular Formula:C10H8Cl2O2
    Molecular Weight;231.07
    CAS Registry Number;84604-17-1
  • Tecovirimat

    Tecovirimat

    Product Name:Tecovirimat
    Molecular Formula:C19H15F3N2O3
    Molecular Weight;376.332
    CAS Registry Number;816458-31-8
  • 4-(4-Ethylpiperazin-1-ly)aniline

    4-(4-Ethylpiperazin-1-ly)aniline

    Product Name:4-(4-Ethylpiperazin-1-ly)aniline
    Molecular Formula:C12H19N3
    Molecular Weight:205.3
    CAS Registry Number:115619-01-7
  • Vecuronium bromide

    Vecuronium bromide

    Product Name:Vecuronium bromide
    Molecular Formula:C34H57BrN2O4
    Molecular Weight;637.73138
    CAS Registry Number;50700-72-6
  • 1,3-Dioxolane

    1,3-Dioxolane

    Product Name:1,3-Dioxolane
    Molecular Formula:C3H6O2
    Molecular Weight:74.08
    CAS Registry Number:646-06-0
  • 1-(tert-butyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one

    1-(tert-butyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one

    Product Name:1-(tert-butyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one
    Molecular Formula:C11H14N2O
    Molecular Weight:190.24
    CAS Registry Number:1455358-06-1
  • Related Blog
  • Reviews

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Related Search

CAS NO 2859-68-9

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept